We present a female patient with linear porokeratosis of her right arm since childhood. At the age of 67 years she additionally developed disseminated superficial actinic porokeratosis (DSAP) involving both lower legs. This uncommon coexistence of two different types of porokeratosis fulfils the clinical criteria of a type 2 segmental manifestation of an autosomal dominant skin disorder, being superimposed on the ordinary nonsegmental lesions and reflecting loss of heterozygosity that occurred at an early developmental stage. In DSAP molecular evidence of this concept is so far lacking, but such proof has already been provided in several other autosomal dominant skin disorders. Molecular analysis of cases of type 2 segmental involvement may help elucidate the genetic defect causing DSAP.
To confirm the clinical diagnosis and to exclude malignancy we performed two skin biopsies of the upper and lower right arm. Histopathological examination revealed typical cornoid lamella confirming the diagnosis of porokeratosis. The diagnosis of linear porokeratosis was made. Due to distressing cosmetic problems we started treatment with topical isotretinoin 0.1% cream once daily and skin care containing 5% urea.
Six years later the patient presented with new skin lesions affecting both lower legs. Physical examination showed multiple, disseminated reddish-brown annular lesions with prominent hyperkeratotic ridges. These skin eruptions were smaller and less conspicuous than those of the right arm ( fig. 1b ). The histological examination demonstrated a porokeratosis, so that the clinical diagnosis of disseminated superficial actinic porokeratosis (DSAP) was confirmed. Parents and siblings were not affected. Only a minimal response was noted after 8-week treatment with imiquimod 5% cream.
Discussion
Porokeratosis is a group of genetic disorders characterized by a clonal proliferation of keratinocytes. Up to date, 6 different types have been identified. These include besides classic porokeratosis of Mibelli (PM), disseminated superficial actinic porokeratosis (DSAP), 'linear porokeratosis' ('LP'), porokeratosis palmaris et plantaris disseminata (PPPD), disseminated superficial porokeratosis (DSP) and porokeratosis palmaris et plantaris punctata (PPPP). A distinctive histologic feature of all porokeratotic variants is the cornoid lamella which is characterized by a column of parakeratotic cells extending through the surrounding orthokeratotic stratum corneum, a decreased stratum granulosum beneath the parakeratotic column, dyskeratosis in the underlying stratum malpighii and a dermal perivascular lymphocytic infiltrate.
The classic porokeratosis of Mibelli has a strong family history suggestive of autosomal dominant inheritance and can occur at every age. The multiple reddish-brown lesions with atrophic center mainly develop disseminated on the extremities, less often on the trunk or glans penis. So far, only one case of type 2 segmental porokeratosis of Mibelli was found in the literature [1] . By contrast, DSAP emerges after ultraviolet-exposure and therefore occurs in sun-exposed areas like the back of the hand, the forearms and lower legs and the face. DSAP is an autosomal dominant disorder. Its molecular basis is so far unknown, although three different genetic loci and diverse candidate genes have been proposed [2, 3] . However, these data could not be reproduced by other groups so far and require further confirmation [4, 5] . Except for sun exposure, several risk factors have been associated with the development of DSAP, including virus infection, immunosuppression and radioactivity. Linear porokeratosis usually arises in childhood and follows Blaschko's lines.
The coexistence of two different clinical forms of porokeratosis in a single individual is rare. To our knowledge, only 26 cases have been documented in the literature, so far. The most common combination is -as observed in the present patient -a linear porokeratosis combined with a DSAP. Linear porokeratosis is usually the first type of porokeratosis that is apparent in childhood, while DSAP appears later during the fourth and fifth decades of life.
Following the concept by Happle, two types of segmental manifestation of an autosomal dominant skin disease can be distinguished. Type 1 reflects heterozygositiy for a new postzygotic mutation, as exemplified by a case of unilateral DSAP induced by immunosuppressive therapy of pemphigus vulgaris in a 68-year-old patient [6] . By contrast, type 2 results from loss of the corresponding wild-type allele occurring in a heterozygous embryo and reflects either homozygosity or hemizygosity for the underlying mutation, giving rise to rather pronounced segmental lesions that are superimposed on the ordinary nonsegmental phenotype [7] [8] [9] . Recently, molecular proof of the theory of type 2 segmental manifestation has been provided in Hailey-Hailey disease [10] , Cowden syndrome [11, 12] and Darier disease [13] . However, the concept of a type 2 segmental manifestation of an autosomal dominant skin disorder has been proposed for several other diseases and is awaiting further molecular proof (table 1).
Following Happle's theory, the present case of porokeratosis fulfills the criteria of a type 2 segmental manifestation of an autosomal dominant skin disorder [7] . This concept implies that a patient with DSAP carries a heterozygous germline mutation. Loss of the corresponding wild-type allele due to a somatic crossing-over or deletion may occur at an early developmental stage and give rise to a daughter cell representing a precursor of a clone which grows out in a linear pattern following the lines of Blaschko. This theory explains why the segmental lesions appear earlier in life and are more pronounced than the disseminated ones. The allelic loss may represent an initial stage in the process of carcinogenesis and may be responsible for the malignant potential being highest for the linear lesions [9] .
In conclusion, our case highlights the importance of recognizing such uncommon segmental involvement being superimposed on the ordinary nonsegmental lesions. Molecular analysis of such cases may help elucidate the etiology of DSAP and corroborate the theory of type 2 segmental manifestation of this disorder. 
